menu toggle

The first oral Bordetella bronchiseptica and canine parainfluenza virus vaccine with patented Immuno-Mist-R™ technology

Nobivac Intra-Trac Oral BbPi

Innovation that is exclusively Nobivac®

Nobivac Intra-Trac Oral BbPi packaging
Nobivac Intra-Trac Oral BbPi packaging
Vaccine guidelines recommend mucosal protection for upper respiratory diseases.1 Until now, oral vaccines have not included CPIV. Only intranasal vaccines could provide mucosal protection against parainfluenza virus.1

Nobivac® Intra-Trac® Oral BbPi offers a convenient, comfortable solution for mucosal protection in an easy-to-administer oral formulation.
Nobivac Intra-Trac Oral BbPi packaging

We made the impossible possible

  • An oral combination vaccine that delivers protective immunity against 2 of the most common CIRDC pathogens
  • Advanced Immuno-Mist-R™ technology allows for a large surface area of vaccine coverage that induces an effective mucosal immune response
  • Our proprietary formulation stimulates IgA antibodies for effective protection
  • Oral administration offers better comfort for dogs and greater convenience for staff

Twist, mist, and go!

Try the first oral Bordetella bronchiseptica and canine parainfluenza virus vaccine with Immuno-Mist-R™ technology.
Nobivac Intra-Trac Oral BbPi
References
1Vaccination recommendations for general practice. American Animal Hospital Association website. Accessed Sept 8, 2022. https://www.aaha.org/aaha-guidelines/vaccination-canine-configuration/vaccination-recommendations-for-general-practice/